Chris with access to 20 million I am starting to believe this is the main reason for the 1 billion as well. Also it could just be an ace in the pocket for takeover defense as well. This is all around the time we expect bridge data/partnership. They could be worried about the interest that could very quickly generate around Lympro. Like a shark to blood (Shark Week)

As far as Mannkind is concerned, don't even look at it for 12-18 months. When you do it will be worth $30 a share